Bicara Therapeutics announced a CEO change and the appointment of a CFO. The company news from Boston reports management changes involving current president and COO Ryan Cohlhepp.
Bicara Therapeutics Inc. today announced management changes, including a CEO change and the appointment of a CFO. Details of the specific appointments are provided in the main text, while the announcement indicates that organizational changes, including changes to the company's board of directors, are under way.
The news was reported from Boston, and current president and COO Ryan Cohlhepp was mentioned in that capacity. The announcement appears to involve a review of the company's senior management structure.